Bellerophon therapeutics, inc. (BLPH)
CashFlow / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13
Cash flows from operating activities:
Net loss

-

-

-

-

-

-59,674

-61,998

Net Income (Loss) Attributable to Parent

-13,267

2,814

-54,818

-23,814

-46,459

-

-

Adjustments to reconcile net loss to net cash used in operating activities:
Fair Value Adjustment of Warrants

-2,682

-24,877

30,403

590

0

0

-

Debt Issuance Cost

-

-

-

-

-

0

-

Stock based compensation

2,152

2,955

2,841

2,758

1,751

1,839

1,721

Depreciation

348

362

373

400

377

388

429

Warrant Amendment Charge

674

0

0

-

-

-

-

Accretion and amortization of discounts and premiums on marketable securities, net

0

0

6

-34

-45

0

-149

Issuance costs attributable to common stock warrant liability

0

0

111

415

0

-

-

Changes in operating assets and liabilities:
Prepaid expenses and other current assets

-245

-2,709

-2,972

946

3,783

50

-94

Restricted cash held for Ikaria, Inc.

-

-

-

-

-10,812

10,812

0

Restricted cash held as security deposit

-

-

-

-

-457

0

0

Other non-current assets

0

-54

-1,437

-5,210

6,701

0

0

Accounts payable, accrued research and development and accrued expenses

-406

488

791

-1,860

-1,849

-2,914

2,374

Amounts due to Ikaria, Inc.

-

-

-

-

-

661

0

Net cash used in operating activities

-

-

-

-

-

-70,562

-57,231

Net cash used in operating activities

-12,936

-15,495

-15,896

-17,213

-46,264

-

-

Cash flows from investing activities:
Capital expenditures

-

-

-

22

458

0

727

Purchase of marketable securities

0

0

5,981

0

22,757

0

0

Proceeds from sale of marketable securities

0

3,000

8,558

12,221

4,910

0

0

Net cash provided by investing activities

0

3,000

2,577

12,199

-18,305

-

-

Cash flows from financing activities:
Net cash provided by investing activities

-

-

-

-

-

0

-727

Proceeds received from exercise of warrants

0

190

2,299

0

0

-

-

Contribution from Ikaria, Inc. in connection with Spin-Out

-

-

-

-

-

80,000

0

Contributions from Ikaria, Inc., net

-

-

-

-

-

9,252

57,958

Payment of offering expenses related to the secondary offering

-

-

-

-

-

1,912

0

Repurchase of units

-

-

-

-

-

29

0

Proceeds from sale of membership units

-

-

-

-

1

0

0

Proceeds received from exercise of options

0

4

0

0

186

66

0

Proceeds from issuance of common stock in Public Offering

6,236

0

0

2,144

0

-

-

Proceeds from exercise of warrants pending issuance of common shares

0

0

231

0

0

-

-

Proceeds from sale of Units in Secondary Offering, net of commissions and offering expenses

0

0

-235

11,191

0

-

-

Proceeds from sale of Units in PIPE Offering, net of offering expenses

0

-28

22,759

-

-

-

-

Proceeds from sale of Units in PIPE Offering, net of offering expenses

-

-

-

0

0

-

-

Proceeds from sale of common stock in ATM Offering, net of commissions and offering expenses

6,236

0

0

2,144

0

0

-

Proceeds from sale of Units in Direct Offering, net of commissions and offering expenses

0

0

2,730

0

0

0

-

Tax withholding payments for stock compensation

69

0

0

128

0

0

-

Cash proceeds from issuance of common stock from initial public offering, net of issuance costs

-

-

-

-

53,827

0

0

Net cash provided by financing activities

-

-

-

-

-

87,377

57,958

Net cash provided by (used in) financing activities

6,167

166

27,784

13,207

54,014

-

-

Net change in cash, cash equivalents and restricted cash

-6,769

-12,329

14,465

8,193

-

-

-

Non-cash financing activities:
Net change in cash and cash equivalents

-

-

-

-

-10,555

16,815

0

Non-cash investing activities:
Change in unrealized holding gains on marketable securities, net

0

4

-4

19

-

-

-

Investment by Ikaria, Inc., net

-

-

-

-

-

7,491

-581

Change in unrealized holding gains on marketable securities, net

-

-

-

-

-19

0

0

Contribution of property, plant and equipment from Ikaria, Inc.

-

-

-

-

-

-

83

Non-cash financing activities:
Conversion of warrant liability to common stock upon exercise of warrants

0

483

4,411

0

0

-

-

Reclassification of warrant liability to equity on amendment of warrant agreements

4,009

0

0

-

-

-

-

New right of use asset and operating lease

322

0

0

-

-

-

-